|
´º½º Ȩ |
|
ÇØ¿Ü´º½º |
|
ÇØ¿Ü´º½º |
|
|
ÇÏÁöºÒ¾ÈÁõÈıº, ÀÚ»ì ±âµµ À§Çè 2.8¹è ³ô¿©
|
°¡¸¸È÷ ¾É¾Æ Àְųª ´©¿ì¸é ´Ù¸®°¡ ±ÙÁú±ÙÁúÇÏ°í ¹ú·¹°¡ ±â¾î°¡´Â µíÇÑ ºÒÄèÇÑ ´À³¦ÀÌ µé¾î ´Ù¸®¸¦ ÀÚ²Ù ¿òÁ÷ÀÌ°Ô µÇ´Â ÇÏÁöºÒ¾ÈÁõÈıº(RLS: restless legs syndrome) ȯÀÚ.. À̹̿¬ ±âÀÚ/dongdongtro@naver.com | 10-17 15:04 |
|
|
|
¼¿¸®¾Çº´ ȯÀڵ鿡°Ô ±Û·çÅÙ ÇÁ¸®´Â ¾ç³¯ÀÇ °Ë
|
¸ö ¾È¿¡ ±Û·çÅÙÀ» ó¸®ÇÏ´Â È¿¼Ò°¡ ¾ø¾î¼ »ý±â´Â ÁúȯÀÎ ¼¿¸®¾Ç º´ ȯÀڵ鿡°Ô ±Û·çÅÙÀ» ÇÔÀ¯ÇÏÁö ¾ÊÀº ±Û·çÅÙ ÇÁ¸®(gluten free) ½Ä´ÜÀº ¾ç³¯ÀÇ °ËÀ̶ó´Â ¿¬±¸°á°ú°¡ ¹ßÇ¥.. À̹̿¬ ±âÀÚ/dongdongtro@naver.com | 10-17 10:13 |
|
|
|
FDA, ÈÀÌÀÚ À¯¹æ¾Ï Ä¡·áÁ¦ 'Å»¶óÁ¶Æĸ³' ½ÂÀÎ
|
FDA°¡ ºÎ¸ð¿¡°Ô¼ ¹°·Á¹ÞÀº À¯ÀüÀÚ º¯ÀÌ¿Í ¿¬°üµÈ À¯¹æ¾ÏÀ» Ä¡·áÇØÁÖ´Â ÈÀÌÀÚ»çÀÇ Å»¶óÁ¶Æĸ³(talazoparib)¸¦ ½ÂÀÎÇß´Ù. 17ÀÏ(ÇöÁö½Ã°¢) ·ÎÀÌÅÍ Åë½ÅÀº FDA À¥»çÀÌÆ®.. À̹̿¬ ±âÀÚ/dongdongtro@naver.com | 10-17 08:55 |
|
|
|
COPDÀÖ´Â PTSD ȯÀÚ, ÀÚ³«½º º¹¿ëÇϸé ÀÚ»ì À§Çè Áõ°¡
|
¸¸¼ºÆó¼â¼ºÆóÁúȯ(Chronic Obstructive Pulmonary Disease:COPD)°ú ¿Ü»ó ÈÄ ½ºÆ®·¹½º Àå¾Ö(post-traumatic stress disorder: PTSD)°¡ Àִ ȯÀÚÀÇ °æ¿ì º¥Á¶µð¾ÆÁ¦ÇÉ°è ¾à¹°.. À̹̿¬ ±âÀÚ/dongdongtro@naver.com | 10-17 08:27 |
|
|
|
|
|
|
|
|
|
|